Ads
    Related paper
  1. INFLUENCE OF VILDAGLIPTIN AND GLIQUIDONE COMBINATION ON P-GLYCOPROTEIN FUNCTIONAL ACTIVITY AND EXPRESSION ON THE BACKGROUND OF NORM AND IN EXPERIMENTAL ALLOXAN-INDUCED DIABETES MELLITUS TYPE 2
  2. GLIQUIDONE INFLUENCE ON THE P-GLYCOPROTEIN EXPRESSION ON THE BACKGROUND OF NORM AND EXPERIMENTAL ALLOXAN-INDUCED DIABETES MELLITUS TYPE 2
  3. Effect of Vildagliptin on the Level of P-Glycoprotein Expression in Normal Conditions and Alloxan–Induced Type 2 Diabetes Mellitus
  4. Evaluation of antidiabetic and antihyperlipidimic activity of Kefir in alloxan induced diabetes mellitus rat
  5. EXPLORE THE NATURE AND WITHDRAWAL PERIOD OF SULFONYLUREA II GENERATION DERIVATIVE ? GLIQUIDONE ON FUNCTIONAL ACTIVITY OF THE DRUG TRANSPORTER P-GLYCOPROTEIN
  6. Hypoglycemic Activity and Safety Assessment of Pediococcus acidilactici Strain DNH16 in Experimental Type 2 Diabetes Mellitus Rats Induced with Streptozotocin
  7. The impact of three combinations vildagliptin/metformin, vildagliptin/pioglitazone, and metformin/pioglitazone on glycemic control and atherogenic dyslipidemia in patients with Type 2 diabetes mellitus
  8. THE INFLUENCE OF EXPERIMENTAL SUBACUTE HYPOBARIC HYPOXIA ON P-GLYCOPROTEIN FUNCTIONAL ACTIVITY
  9. The Dynamics of Biochemical Parameters in Patients with Climacteric Syndrome in the Background of Diabetes Mellitus Type II and under the Influence of Complex Therapy with the Use of Climact-hel and Mulimen
  10. The Influence of Performance Therapy with Statins on Androgen Balance in Patients with Stable Angina in Combination with Type 2 Diabetes Mellitus